Hainan Cancer Hospital (Lecheng)

International Hospital in Boao, China · 海南肿瘤医院乐城院区

Hainan Cancer Hospital's Lecheng campus provides access to over 150 oncology drugs not yet available in mainland China, including the latest ADC drugs, targeted therapies, and immunotherapy combinations. The hospital offers CAR-T cell therapy and serves as a major oncology center within the Boao Lecheng Pilot Zone, treating patients from across Asia who seek access to cutting-edge cancer treatments.

Boao Lecheng International Medical Tourism Pilot Zone, Qionghai, Hainan, Boao

+86-898-67866110

Overview — Hainan Cancer Hospital (Lecheng)

Scale

Specialized cancer hospital with 150+ innovative drugs

Total Beds

300

City

Boao, Hainan

Departments

Medical OncologySurgical OncologyRadiation OncologyHematologyCAR-T TherapyImmunotherapy

Leading Surgeries & Procedures

The hospital provides CAR-T cell therapy for hematologic malignancies, access to ADC drugs including Enhertu (T-DXd) and datopotamab deruxtecan, novel targeted therapies (sotorasib, adagrasib for KRAS mutations; capmatinib, tepotinib for MET alterations), and immunotherapy combinations still in trials elsewhere. Rare cancer drugs including entrectinib and larotrectinib for NTRK fusion-positive tumors are available.

Key Surgical Departments

Medical Oncology provides access to 150+ innovative drugs covering all major cancer types. The CAR-T Therapy Center is one of four such centers in the Lecheng zone. Radiation Oncology offers advanced treatment planning. Surgical Oncology performs complex tumor resections. The Hematology Department specializes in blood cancers with access to novel therapies.

Notable Physicians

The hospital's oncology team includes specialists trained in administering novel therapies including CAR-T, ADCs, and bispecific antibodies. The medical staff coordinates with pharmaceutical companies to ensure drug availability and proper administration protocols.